Showing results (471-480 of 636) with videos related to

Sort By:
Pageof 64
Advanced Healthcare Materials|March 21, 2026
A Physiological Microfluidic Blood-Brain-Barrier Model for In Vitro Study of Nanoparticle Trafficking and AccumulationBryan B Nguyen, Neona M Lowe, Sophia Kellogg, et al.
Cell Death and Differentiation|November 12, 2016
The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppressionJulie M Lowe, Thuy-Ai Nguyen, Sara A Grimm, et al.
Science Immunology|December 23, 2018
The TNFRSF members CD27 and OX40 coordinately limit TH17 differentiation in regulatory T cellsKelly A Remedios, Bahar Zirak, Priscila Munoz Sandoval, et al.
Nucleic Acids Research|January 10, 2003
Plant snoRNA databaseJohn W S Brown, Manuel Echeverria, Liang-Hu Qu, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 25, 2006
Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytesMary Peace McRae, Carolina M Lowe, Xianbin Tian, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
A physiological microfluidic blood-brain-barrier model for in vitro study of nanoparticle trafficking and accumulationBryan B Nguyen, Neona M Lowe, Sophia Kellogg, et al.
AJNR. American Journal of Neuroradiology|December 17, 2011
A validation study of multicenter diffusion tensor imaging: reliability of fractional anisotropy and diffusivity valuesR J Fox, K Sakaie, J-C Lee, et al.
Immunity|March 21, 2019
Treg-Cell Control of a CXCL5-IL-17 Inflammatory Axis Promotes Hair-Follicle-Stem-Cell Differentiation During Skin-Barrier RepairAnubhav N Mathur, Bahar Zirak, Ian C Boothby, et al.
American Heart Journal|June 25, 2005
Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?Vladimir Dzavik, Lynn A Sleeper, Michael H Picard, et al.
Plos One|March 29, 2018
Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapyNatalie M Lowe, Lucy E Kershaw, Jonathan M Bernstein, et al.
Pageof 64